Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fenofibrate and Pharmacogenetic Impact in Dyslipidemia (FPI)

This study has been completed.
Sponsor:
Collaborator:
Laval University
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00613613
First received: January 31, 2008
Last updated: December 1, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)